Abstract
ABSTRACT: Phenylacetylglutamine (PAG), the amino acid acetylation product of phenylacetate (or phenylbutyrate after β-oxidation) was evaluated as a waste nitrogen product in patients with inborn errors of urea synthesis. A boy with carbamyl phosphate synthetase deficiency receiving a low nitrogen intake excreted SO-90% of administered phenylacetate or phenylbutyrate as PAG. The amount of PAG nitrogen excreted varied from 38–44% of his dietary nitrogen, similar to the relationship between urea nitrogen and dietary nitrogen found in normal subjects receiving low dietary nitrogen. With few exceptions, neither phenylacetate nor phenylbutyrate accumulated in plasma. Treatment with relatively high dose phenylacetate or phenylbutyrate (0.5–0.6 g/kg/d) resulted in normal daytime levels of glutamine. These data suggest that PAG may replace urea as a waste nitrogen product when phenylbutyrate is administered at a dose that yields PAG nitrogen excretion equal to 40–44% of a low nitrogen intake.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brusilow, S. Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion. Pediatr Res 29, 147–150 (1991). https://doi.org/10.1203/00006450-199102000-00009
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199102000-00009
This article is cited by
-
Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights
Frontiers of Medicine (2024)
-
Metabolic signature of HepaRG cells exposed to ethanol and tumor necrosis factor alpha to study alcoholic steatohepatitis by LC–MS-based untargeted metabolomics
Archives of Toxicology (2023)
-
Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes
Nutrition & Diabetes (2022)
-
Urea cycle disorders—update
Journal of Human Genetics (2019)
-
Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment
Metabolic Brain Disease (2018)